Metraipolis › archive › dc_9be2a0ebb2bb

ZNF473 as a biomarker and potential therapeutic target in cancer: integrated bioinformatics and experimental evidence with a focus on hepatocellular carcinoma — Europe PMC PMID:42222414

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42222414
DOI: 10.3389/fonc.2026.1810579
License (as archived): solo-consultazione
Archived: 2026-10-08T10:19:06.155Z
SHA-256 of the archived text: 4b608ee87d314a6d23e7e0cdaaa35594eeff65ae08cbab2f4afb2063fd9aa06a
Stable URL of this page: https://metraipolis.com/documento/dc_9be2a0ebb2bb

How to cite

ZNF473 as a biomarker and potential therapeutic target in cancer: integrated bioinformatics and experimental evidence with a focus on hepatocellular carcinoma — Europe PMC PMID:42222414 — Europe PMC (en), https://europepmc.org/article/MED/42222414 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9be2a0ebb2bb (Metraipolis archive dc_9be2a0ebb2bb, sha256 4b608ee87d314a6d23e7e0cdaaa35594eeff65ae08cbab2f4afb2063fd9aa06a)

BibTeX

@misc{dc9be2a0ebb2bb,
  title = {ZNF473 as a biomarker and potential therapeutic target in cancer: integrated bioinformatics and experimental evidence with a focus on hepatocellular carcinoma — Europe PMC PMID:42222414},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42222414},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9be2a0ebb2bb; sha256 4b608ee87d314a6d23e7e0cdaaa35594eeff65ae08cbab2f4afb2063fd9aa06a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42222414. Agents can read the archived copy with the MCP tool read_document.